Last reviewed · How we verify
NCT04259866
FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS
trial in Breast Cancer Screening in 4,500 participants. Completed in 1 January 2020.
1 January 2020
Quick facts
| Lead sponsor | "G Criscuoli" Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,500 |
| Start date | 1 January 2019 |
| Primary completion | 1 January 2020 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Italy |
Conditions studied
- Breast Cancer Screening — all drugs for Breast Cancer Screening →
Sponsor
"G Criscuoli" Hospital
Who can join
Adults 50 to 69, female only, with Breast Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To analyse false positives in breast cancer screening with tomosynthesis versus 2D mammography. The Avellino Breast Tomosynthesis Screening Trial is a observational population-based study that analyze souspicious findings in tomosynthesis slice images. This study is based on two years screening and tomosynthesis was analzyed by two expert breast radiologists.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04259866
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Screening
Currently open trials in the same condition.
- NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
- NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
- NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
- NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
- NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04259866 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by "G Criscuoli" Hospital
- Last refreshed: 7 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04259866.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing